BAAM
IART icon

Baker Avenue Asset Management’s Integra LifeSciences IART Stock Holding History

Baker Avenue Asset Management’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-36
Closed -$1.38K – 875
2023
Q3 		$1.38K Buy
36
+30
+500% +$1.26K ﹤0.01% 1208
2023
Q2 		$247 Buy
+6
New +$289 ﹤0.01% 1546

Other funds holding IART

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baker Avenue Asset Management's IART Position: Q4 2023 in Review

Baker Avenue Asset Management sold out of Integra LifeSciences (IART) in Q4 2023, closing a stake of 36 shares — an estimated $1.38K sold.

Baker Avenue Asset Management first reported a position in IART in Q2 2023 and held it in 2 quarters. The position peaked at $1.38K in Q3 2023. 284 funds tracked by Wall St. Rank hold IART as of Q4 2023.

  • Baker Avenue Asset Management reported no remaining Integra LifeSciences position as of Q4 2023 after selling out during the quarter.
  • Baker Avenue Asset Management sold 36 Integra LifeSciences shares in Q4 2023, an estimated $1.38K.
  • Baker Avenue Asset Management first reported a position in Integra LifeSciences in Q2 2023 and held it in 2 quarters.
  • Baker Avenue Asset Management's Integra LifeSciences position peaked at $1.38K in Q3 2023.
  • 284 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2023.

Based on Baker Avenue Asset Management's 13F filing for Q4 2023, filed 13 Feb 2024.